Introduction Osteoporosis and fragility fracture are more frequently found in systemic lupus erythematosus (SLE) patients than in normal population. This study aims to determine the risk factors in ...

Objectives To define a clinically meaningful treatment response definition for haemolytic anaemia, that will form part of a novel multidomain outcome measure for SLE clinical trials.Methods An ...

Think twice before drinking that poolside cocktail.

Patients with lupus face a high burden of comorbidities, with the presence of at least one of seven key conditions linked to 55%-60% lower odds of achieving remission or a low disease activity state.

In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss diagnostic and treatment gaps in disease management.

Almost 90% of a cohort of patients with systemic lupus erythematosus reported experiencing depression or depressive symptoms ...

Lupus is more common in Black people, and symptoms can be different too. Here's what to look out for and how to treat it.

Obinutuzumab, a glycoengineered type II anti-CD20 monoclonal antibody, induces potent B-cell depletion and is approved for the treatment of active lupus nephritis. Its efficacy and safety in patients ...

The U.S. State Department late Friday announced it had approved two arms sales to Israel and Saudi Arabia worth $6.67 billion and $9 billion. The sales come as the Trump administration moves forward ...

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the self-administered drug formulation in lupus patients with a positive phase ...

Dec. 18, 2025 -- At least 1.5 million people in the United States are living with lupus, a chronic and often misunderstood autoimmune disease. What are the most common myths about lupus – and who does ...